Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
RESTEM Announces First-Patient-Dosed in the Phase 1/2a Study of Restem-L in Facioscapulohumeral Muscular Dystrophy
-
Rehab 4 Addiction CEO Releases New Article Sharing Effective Tips for Going Sober This December, And Actually Enjoying It
-
Digits Launches Ask Digits, a 24/7 AI Assistant for Real-Time Financial Answers and Actions
-
Westwood Holdings Group, Inc. Recognized in Pensions & Investments’ Best Places to Work in Money Management
-
NEXE Innovations Sees Growing Repeat Demand for Its Compostable Coffee Pods; ecoBeans Orders 70,000 Pods, Its Largest Order to Date
-
Refined Energy Corp. Receives Formal Drill Program Proposal for Dufferin Project Drill Program
-
Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society
-
Wicked Reserve Dispensary Expands Range with New Refrigerated THC Beverage Section
-
Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
-
HyOrc Secures 10-Year Offtake Commitment for Green Methanol Pilot; Global Energy Players Show Investment Interest In Expansion
-
Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
-
Abundia Global Impact Group, Inc. Initiates Trading Under New Ticker Symbol “AGIG”
-
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy
-
FutureFuel Announces Director and Chairman of the Board Appointment
-
SPX Technologies to Acquire Crawford United
-
EBZT Announces Sports Edge AI Development for Polymarket Sports Prediction Markets
-
Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta
-
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf
-
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogene
-
ReserveOne Announces Filing of Registration Statement on Form S-4 with the SEC for Proposed Business Combination with M3-Brigade Acquisition V Corp.
-
nCino Announces Stock Repurchase Program
-
Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum
-
Osisko Development Launches Fully-Funded 70,000-Meter Exploration Drilling Campaign Targeting New Discoveries at Cariboo Gold Project
-
BIO-key Answers the Call for Secure, Modern Authentication with New Passwordless Innovations at the 2025 Gartner® IAM Summit: North America
-
Soleo Health Appoints Jody Thompson as New Senior Vice President of Business Development, Rare Disease
-
Ascent Solar Technologies Announces Up To $5.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Clip Money Inc. Announces Expanded Partnership with Centennial Delivering Cash Management Solutions to 1600+ Retailers
-
CALIFORNIA BANCORP ANNOUNCES FIRST CASH DIVIDEND
-
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
-
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Gabelli Launches Keeley Dividend ETF (KDVD)
-
Brazil Potash Achieved Major 2025 Milestones, Positions for Construction Advancement in 2026
-
How Fenstermaker Uses Handheld Lidar to Map Schools for 911 Safety and Response
-
Westwood Holdings Group, Inc. Recognized in Pensions & Investments’ Best Places to Work in Money Management
-
ASML reports transactions under its current share buyback program
-
Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study
-
Total Return Securities Fund Announces Expiration of Rights Offering
-
Transcontinental Inc. enters into Agreement to Sell its Packaging Business
-
Bang & Olufsen A/S - Transactions in connection with share buyback programme to hedge the company’s share-based incentive programmes
-
Zelluna ASA: New share capital registered
-
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
-
ContextLogic to Acquire US Salt from Emerald Lake in $907.5 Million Transaction, Creating New Business Ownership Platform in Partnership with Abrams Capital and BC Partners Credit
-
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
-
Stock Yards Bancorp Announces Promotion of William Otten to Chief Credit Officer of the Company as William Dishman Sets Retirement Date
-
Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
-
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at
-
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
-
Onex Completes Final Realization of Ryan Specialty, Delivering Strong Investing Results
-
Digi Power X Appoints Chief Technology Officer
-
Gemini to Participate in Goldman Sachs 2025 Financial Services Conference
